Chinese SLE Treatment And Research Group
21
7
8
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
4.8%
1 terminated/withdrawn out of 21 trials
66.7%
-19.8% vs industry average
71%
15 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
Role: lead
Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus
Role: lead
Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus
Role: lead
Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
Role: lead
The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis
Role: lead
Telitacicept for the Treatment of Refractory RA
Role: lead
Chinese Rheumatism Biobank(CRB)
Role: lead
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus
Role: lead
A Study on the Prevention and Treatment of GIOP With Eldecalcitol
Role: lead
Anti-CD20 Antibodies for Treatment of SLE-PAH
Role: lead
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
Role: lead
The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis
Role: lead
Bortezomib for the Treatment of Refractory Rheumatoid Arthritis
Role: lead
Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis
Role: lead
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Role: lead
Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)
Role: lead
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Role: lead
Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis
Role: lead
Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
Role: lead
Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis
Role: lead